169 related articles for article (PubMed ID: 27667133)
1. Hepatitis E virus RNA in Australian blood donations.
Shrestha AC; Flower RL; Seed CR; Keller AJ; Harley R; Chan HT; Hoad V; Warrilow D; Northill J; Holmberg JA; Faddy HM
Transfusion; 2016 Dec; 56(12):3086-3093. PubMed ID: 27667133
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis E virus RNA in Australian blood donors: prevalence and risk assessment.
Hoad VC; Seed CR; Fryk JJ; Harley R; Flower RLP; Hogema BM; Kiely P; Faddy HM
Vox Sang; 2017 Oct; 112(7):614-621. PubMed ID: 28833229
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis E virus infection in the Irish blood donor population.
O'Riordan J; Boland F; Williams P; Donnellan J; Hogema BM; Ijaz S; Murphy WG
Transfusion; 2016 Nov; 56(11):2868-2876. PubMed ID: 27522065
[TBL] [Abstract][Full Text] [Related]
4. Molecular and serological infection marker screening in blood donors indicates high endemicity of hepatitis E virus in Poland.
Grabarczyk P; Sulkowska E; Gdowska J; Kopacz A; Liszewski G; Kubicka-Russel D; Baylis SA; Corman VM; Noceń E; Piotrowski D; Antoniewicz-Papis J; Łętowska M
Transfusion; 2018 May; 58(5):1245-1253. PubMed ID: 29492976
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of Acute Hepatitis E Virus Infections in Swiss Blood Donors 2018-2020.
Niederhauser C; Gowland P; Widmer N; Amar El Dusouqui S; Mattle-Greminger M; Gottschalk J; Frey BM
Viruses; 2024 May; 16(5):. PubMed ID: 38793625
[TBL] [Abstract][Full Text] [Related]
6. HEV-positive blood donations represent a relevant infection risk for immunosuppressed recipients.
Westhölter D; Hiller J; Denzer U; Polywka S; Ayuk F; Rybczynski M; Horvatits T; Gundlach S; Blöcker J; Schulze Zur Wiesch J; Fischer N; Addo MM; Peine S; Göke B; Lohse AW; Lütgehetmann M; Pischke S
J Hepatol; 2018 Jul; 69(1):36-42. PubMed ID: 29551705
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis E and blood donation safety in selected European countries: a shift to screening?
Domanović D; Tedder R; Blümel J; Zaaijer H; Gallian P; Niederhauser C; Sauleda Oliveras S; O'Riordan J; Boland F; Harritshøj L; Nascimento MSJ; Ciccaglione AR; Politis C; Adlhoch C; Flan B; Oualikene-Gonin W; Rautmann G; Strengers P; Hewitt P
Euro Surveill; 2017 Apr; 22(16):. PubMed ID: 28449730
[TBL] [Abstract][Full Text] [Related]
8. Low transfusion transmission of hepatitis E among 25,637 single-donation, nucleic acid-tested blood donors.
Harritshøj LH; Holm DK; Saekmose SG; Jensen BA; Hogema BM; Fischer TK; Midgley SE; Krog JS; Erikstrup C; Ullum H
Transfusion; 2016 Sep; 56(9):2225-32. PubMed ID: 27385646
[TBL] [Abstract][Full Text] [Related]
9. [Hepatitis E virus: Blood transfusion implications].
Gallian P; Piquet Y; Assal A; Djoudi R; Chiaroni J; Izopet J; Tiberghien P
Transfus Clin Biol; 2014 Nov; 21(4-5):173-7. PubMed ID: 25267201
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis E virus in blood donors in England, 2016 to 2017: from selective to universal screening.
Harvala H; Hewitt PE; Reynolds C; Pearson C; Haywood B; Tettmar KI; Ushiro-Lumb I; Brailsford SR; Tedder R; Ijaz S
Euro Surveill; 2019 Mar; 24(10):. PubMed ID: 30862338
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis E virus: seroprevalence and frequency of viral RNA detection among US blood donors.
Stramer SL; Moritz ED; Foster GA; Ong E; Linnen JM; Hogema BM; Mak M; Chia CP; Dodd RY
Transfusion; 2016 Feb; 56(2):481-8. PubMed ID: 26434952
[TBL] [Abstract][Full Text] [Related]
12. Seroprevalence of hepatitis E virus (HEV) and detection of HEV RNA with a transcription-mediated amplification assay in blood donors from Catalonia (Spain).
Sauleda S; Ong E; Bes M; Janssen A; Cory R; Babizki M; Shin T; Lindquist A; Hoang A; Vang L; Piron M; Casamitjana N; Koppelman M; Danzig L; Linnen JM
Transfusion; 2015 May; 55(5):972-9. PubMed ID: 25403913
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis E virus in blood components: a prevalence and transmission study in southeast England.
Hewitt PE; Ijaz S; Brailsford SR; Brett R; Dicks S; Haywood B; Kennedy IT; Kitchen A; Patel P; Poh J; Russell K; Tettmar KI; Tossell J; Ushiro-Lumb I; Tedder RS
Lancet; 2014 Nov; 384(9956):1766-73. PubMed ID: 25078306
[TBL] [Abstract][Full Text] [Related]
14. An assessment of hepatitis E virus (HEV) in US blood donors and recipients: no detectable HEV RNA in 1939 donors tested and no evidence for HEV transmission to 362 prospectively followed recipients.
Xu C; Wang RY; Schechterly CA; Ge S; Shih JW; Xia NS; Luban NL; Alter HJ
Transfusion; 2013 Oct; 53(10 Pt 2):2505-11. PubMed ID: 23829163
[TBL] [Abstract][Full Text] [Related]
15. A Public Health initiative on hepatitis E virus epidemiology, safety and control in Portugal--study protocol.
Mesquita JR; Myrmel M; Stene-Johansen K; Øverbø J; Nascimento MS
BMC Infect Dis; 2016 Jan; 16():17. PubMed ID: 26774897
[TBL] [Abstract][Full Text] [Related]
16. [Assessment of a transfusion emergent risk: the case of HEV].
Pillonel J; Gallian P; Sommen C; Couturier E; Piquet Y; Djoudi R; Laperche S;
Transfus Clin Biol; 2014 Nov; 21(4-5):162-6. PubMed ID: 25267205
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis E virus in donor plasma collected in Japan.
Minagi T; Okamoto H; Ikegawa M; Ideno S; Takahashi K; Sakai K; Hagiwara K; Yunoki M; Wakisaka A
Vox Sang; 2016 Oct; 111(3):242-246. PubMed ID: 27280485
[TBL] [Abstract][Full Text] [Related]
18. Incidence and duration of hepatitis E virus infection in Dutch blood donors.
Hogema BM; Molier M; Sjerps M; de Waal M; van Swieten P; van de Laar T; Molenaar-de Backer M; Zaaijer HL
Transfusion; 2016 Mar; 56(3):722-8. PubMed ID: 26559806
[TBL] [Abstract][Full Text] [Related]
19. Low hepatitis E virus RNA prevalence in a large-scale survey of United States source plasma donors.
Roth NJ; Schäfer W; Alexander R; Elliott K; Elliott-Browne W; Knowles J; Wenzel JJ; Simon TL
Transfusion; 2017 Dec; 57(12):2958-2964. PubMed ID: 28833188
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of antibodies to hepatitis E virus among Japanese blood donors: identification of three blood donors infected with a genotype 3 hepatitis E virus.
Fukuda S; Sunaga J; Saito N; Fujimura K; Itoh Y; Sasaki M; Tsuda F; Takahashi M; Nishizawa T; Okamoto H
J Med Virol; 2004 Aug; 73(4):554-61. PubMed ID: 15221899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
